| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.795 | 0.004 | 0.839 | 5 Hydroxytryptamine release stimulant | 0.839 0.003 CID_12297 | CID_12297 | |
| 0.763 | 0.016 | 0.763 | Caspase 9 stimulant | 0.665 0.028 CID_12297 | ||
| 0.708 | 0.008 | 0.806 | Aldehyde oxidase inhibitor | 0.806 0.004 CID_12297 | CID_12297 | |
| 0.675 | 0.004 | 0.675 | GABA C receptor rho-3 antagonist | 0.489 0.029 CID_12297 | ||
| 0.644 | 0.006 | 0.644 | 5 Hydroxytryptamine release inhibitor | 0.643 0.006 CID_12297 | ||
| 0.608 | 0.004 | 0.681 | Alpha-N-acetylglucosaminidase inhibitor | 0.681 0.003 CID_12297 | CID_12297 | |
| 0.606 | 0.018 | 0.687 | Cholesterol antagonist | 0.687 0.009 CID_12297 | CID_12297 | |
| 0.575 | 0.003 | 0.575 | 5 Hydroxytryptamine uptake stimulant | 0.44 0.008 CID_12297 | ||
| 0.553 | 0.009 | 0.553 | Superoxide dismutase inhibitor | 0.425 0.023 CID_12297 | ||
| 0.554 | 0.016 | 0.741 | Immunomodulator | 0.741 0.005 CID_12297 | CID_12297 | |
| 0.541 | 0.003 | 0.636 | Alcohol oxidase inhibitor | 0.636 0.003 CID_12297 | CID_12297 | |
| 0.542 | 0.007 | 0.542 | Peroxidase inhibitor | 0.539 0.007 CID_12297 | ||
| 0.535 | 0.003 | 0.535 | Electron transport complex I inhibitor | 0.509 0.003 CID_12297 | ||
| 0.55 | 0.021 | 0.664 | Vasodilator, peripheral | 0.664 0.009 CID_12297 | CID_12297 | |
| 0.541 | 0.018 | 0.57 | Histamine release inhibitor | 0.57 0.013 CID_12297 | CID_12297 | |
| 0.531 | 0.025 | 0.575 | Immunosuppressant | 0.575 0.016 CID_12297 | CID_12297 | |
| 0.515 | 0.011 | 0.621 | Hypolipemic | 0.621 0.005 CID_12297 | CID_12297 | |
| 0.508 | 0.007 | 0.53 | Anesthetic general | 0.53 0.006 CID_12297 | CID_12297 | |
| 0.52 | 0.025 | 0.52 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.366 0.133 CID_12297 | ||
| 0.488 | 0.003 | 0.524 | Succinate dehydrogenase inhibitor | 0.524 0.003 CID_12297 | CID_12297 | |
| 0.464 | 0.004 | 0.464 | GABA C receptor agonist | 0.304 0.009 CID_12297 | ||
| 0.465 | 0.004 | 0.465 | Tyrosine 3 hydroxylase inhibitor | 0.331 0.021 CID_12297 | ||
| 0.472 | 0.012 | 0.489 | Interleukin 2 agonist | 0.489 0.009 CID_12297 | CID_12297 | |
| 0.458 | 0.003 | 0.458 | Ferrochelatase inhibitor | 0.354 0.005 CID_12297 | ||
| 0.443 | 0.017 | 0.57 | Vasodilator | 0.57 0.007 CID_12297 | CID_12297 | |
| 0.427 | 0.003 | 0.427 | GABA C receptor antagonist | 0.319 0.004 CID_12297 | ||
| 0.422 | 0.005 | 0.422 | DNA polymerase I inhibitor | 0.252 0.017 CID_12297 | ||
| 0.423 | 0.009 | 0.457 | Phospholipase C inhibitor | 0.457 0.008 CID_12297 | CID_12297 | |
| 0.423 | 0.017 | 0.423 | Calcium channel activator | 0.351 0.049 CID_12297 | ||
| 0.42 | 0.016 | 0.487 | Interleukin agonist | 0.487 0.01 CID_12297 | CID_12297 | |
| 0.418 | 0.02 | 0.418 | Psychostimulant | 0.324 0.037 CID_12297 | ||
| 0.397 | 0.018 | 0.397 | RNA-directed DNA polymerase inhibitor | 0.358 0.023 CID_12297 | ||
| 0.419 | 0.045 | 0.593 | Antithrombotic | 0.593 0.017 CID_12297 | CID_12297 | |
| 0.406 | 0.033 | 0.457 | Vasodilator, coronary | 0.457 0.022 CID_12297 | CID_12297 | |
| 0.374 | 0.003 | 0.374 | Acetyl-CoA transferase inhibitor | 0.096 0.014 CID_12297 | ||
| 0.416 | 0.053 | 0.416 | Calpain 2 inhibitor | |||
| 0.384 | 0.024 | 0.384 | Angiogenesis stimulant | 0.271 0.061 CID_12297 | ||
| 0.381 | 0.024 | 0.381 | Sodium/bile acid cotransporter inhibitor | 0.362 0.033 CID_12297 | ||
| 0.379 | 0.032 | 0.408 | Platelet antagonist | 0.408 0.025 CID_12297 | CID_12297 | |
| 0.352 | 0.004 | 0.358 | Adenylate kinase inhibitor | 0.358 0.004 CID_12297 | CID_12297 | |
| 0.367 | 0.021 | 0.367 | Growth hormone agonist | 0.299 0.032 CID_12297 | ||
| 0.354 | 0.009 | 0.354 | Gastrin inhibitor | 0.322 0.02 CID_12297 | ||
| 0.438 | 0.096 | 0.438 | Apoptosis agonist | 0.398 0.115 CID_12297 | ||
| 0.347 | 0.008 | 0.436 | Aldehyde dehydrogenase inhibitor | 0.436 0.005 CID_12297 | CID_12297 | |
| 0.344 | 0.006 | 0.344 | Interleukin 4 antagonist | 0.286 0.009 CID_12297 | ||
| 0.36 | 0.023 | 0.477 | Cyclic AMP phosphodiesterase inhibitor | 0.477 0.008 CID_12297 | CID_12297 | |
| 0.356 | 0.029 | 0.363 | DNA synthesis inhibitor | 0.363 0.028 CID_12297 | CID_12297 | |
| 0.327 | 0.004 | 0.327 | GABA C receptor rho-2 antagonist | 0.192 0.034 CID_12297 | ||
| 0.323 | 0.007 | 0.323 | Neurotrophic factor | 0.294 0.008 CID_12297 | ||
| 0.317 | 0.003 | 0.317 | GABA C receptor rho-1 antagonist | 0.26 0.004 CID_12297 | ||
| 0.369 | 0.059 | 0.48 | Immunostimulant | 0.48 0.032 CID_12297 | CID_12297 | |
| 0.43 | 0.121 | 0.646 | Antiinflammatory | 0.646 0.042 CID_12297 | CID_12297 | |
| 0.322 | 0.013 | 0.322 | Neurotrophic factor enhancer | 0.286 0.022 CID_12297 | ||
| 0.331 | 0.024 | 0.331 | Dual specificity phosphatase inhibitor | 0.163 0.081 CID_12297 | ||
| 0.312 | 0.005 | 0.312 | Porphobilinogen synthase inhibitor | 0.165 0.017 CID_12297 | ||
| 0.31 | 0.004 | 0.31 | Vanilloid agonist | 0.143 0.012 CID_12297 | ||
| 0.307 | 0.004 | 0.307 | Creatine kinase inhibitor | 0.21 0.009 CID_12297 | ||
| 0.32 | 0.018 | 0.32 | Lipocortins synthesis antagonist | 0.196 0.059 CID_12297 | ||
| 0.319 | 0.018 | 0.319 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.272 0.033 CID_12297 | ||
| 0.314 | 0.015 | 0.344 | Protein kinase stimulant | 0.344 0.012 CID_12297 | CID_12297 | |
| 0.35 | 0.056 | 0.368 | Apoptosis antagonist | 0.368 0.048 CID_12297 | CID_12297 | |
| 0.297 | 0.006 | 0.346 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.346 0.005 CID_12297 | CID_12297 | |
| 0.314 | 0.026 | 0.314 | Dual specificity phosphatase 3 inhibitor | 0.181 0.073 CID_12297 | ||
| 0.339 | 0.056 | 0.508 | Spasmolytic | 0.508 0.022 CID_12297 | CID_12297 | |
| 0.326 | 0.044 | 0.326 | Insulysin inhibitor | 0.265 0.083 CID_12297 | ||
| 0.371 | 0.09 | 0.476 | Antibacterial | 0.476 0.048 CID_12297 | CID_12297 | |
| 0.297 | 0.019 | 0.397 | Lipid peroxidase inhibitor | 0.397 0.01 CID_12297 | CID_12297 | |
| 0.304 | 0.027 | 0.304 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.309 | 0.035 | 0.309 | Ca(v)3.3 blocker | |||
| 0.285 | 0.011 | 0.285 | UDP-glucose 4-epimerase inhibitor | 0.284 0.011 CID_12297 | ||
| 0.274 | 0.004 | 0.274 | Prolactin inhibitor | 0.203 0.008 CID_12297 | ||
| 0.304 | 0.035 | 0.304 | Platelet aggregation inhibitor | 0.26 0.048 CID_12297 | ||
| 0.291 | 0.021 | 0.389 | Interferon gamma antagonist | 0.389 0.011 CID_12297 | CID_12297 | |
| 0.272 | 0.006 | 0.31 | Triose-phosphate isomerase inhibitor | 0.31 0.005 CID_12297 | CID_12297 | |
| 0.273 | 0.006 | 0.307 | Phosphofructokinase-1 inhibitor | 0.307 0.005 CID_12297 | CID_12297 | |
| 0.275 | 0.009 | 0.275 | Death-associated protein kinase 2 inhibitor | |||
| 0.273 | 0.007 | 0.325 | Catalase inhibitor | 0.325 0.005 CID_12297 | CID_12297 | |
| 0.268 | 0.005 | 0.268 | Photosensitizer | 0.169 0.022 CID_12297 | ||
| 0.277 | 0.015 | 0.383 | Anesthetic local | 0.383 0.007 CID_12297 | CID_12297 | |
| 0.341 | 0.08 | 0.341 | Transcription factor NF kappa B inhibitor | 0.298 0.095 CID_12297 | ||
| 0.274 | 0.019 | 0.274 | Nitric-oxide synthase stimulant | 0.274 0.019 CID_12297 | ||
| 0.264 | 0.011 | 0.264 | 5 Hydroxytryptamine 3E antagonist | 0.168 0.143 CID_12297 | ||
| 0.253 | 0.003 | 0.271 | Acyl-CoA dehydrogenase inhibitor | 0.271 0.002 CID_12297 | CID_12297 | |
| 0.287 | 0.038 | 0.287 | Platelet adhesion inhibitor | 0.163 0.093 CID_12297 | ||
| 0.252 | 0.005 | 0.252 | Argininosuccinate synthase inhibitor | 0.188 0.008 CID_12297 | ||
| 0.25 | 0.003 | 0.25 | Acetyl-CoA transferase 1 inhibitor | 0.051 0.015 CID_12297 | ||
| 0.251 | 0.004 | 0.251 | Sphingosine 1-phosphate receptor 2 antagonist | 0.197 0.008 CID_12297 | ||
| 0.259 | 0.013 | 0.259 | Cathepsin H inhibitor | 0.242 0.014 CID_12297 | ||
| 0.25 | 0.005 | 0.25 | Arachidonic acid antagonist | 0.238 0.009 CID_12297 | ||
| 0.281 | 0.041 | 0.281 | Calpain inhibitor | 0.174 0.143 CID_12297 | ||
| 0.244 | 0.005 | 0.244 | Sphingosine 1-phosphate receptor 4 antagonist | 0.192 0.011 CID_12297 | ||
| 0.243 | 0.005 | 0.243 | Electrolyte absorption antagonist | 0.203 0.008 CID_12297 | ||
| 0.296 | 0.058 | 0.296 | DNA damaging | 0.229 0.094 CID_12297 | ||
| 0.246 | 0.01 | 0.246 | Nav1.6 sodium channel blocker | 0.176 0.031 CID_12297 | ||
| 0.241 | 0.004 | 0.241 | Sphingosine 1-phosphate receptor 5 antagonist | 0.204 0.01 CID_12297 | ||
| 0.259 | 0.023 | 0.259 | Bone formation stimulant | 0.253 0.024 CID_12297 | ||
| 0.341 | 0.105 | 0.341 | 15-Lipoxygenase inhibitor | |||
| 0.272 | 0.037 | 0.272 | Neuropeptide Y2 antagonist | 0.255 0.051 CID_12297 | ||
| 0.245 | 0.01 | 0.284 | Toll-Like receptor 2 antagonist | 0.284 0.005 CID_12297 | CID_12297 | |
| 0.262 | 0.028 | 0.3 | Insulin sensitizer | 0.3 0.016 CID_12297 | CID_12297 | |
| 0.235 | 0.005 | 0.252 | Sphingomyelinase inhibitor | 0.252 0.004 CID_12297 | CID_12297 | |
| 0.237 | 0.006 | 0.237 | TRPA1 agonist | 0.219 0.008 CID_12297 | ||
| 0.234 | 0.005 | 0.238 | Adenylate cyclase stimulant | 0.238 0.005 CID_12297 | CID_12297 | |
| 0.23 | 0.002 | 0.23 | Ca2+-transporting ATPase inhibitor | 0.208 0.003 CID_12297 | ||
| 0.244 | 0.019 | 0.267 | Cholesterol synthesis inhibitor | 0.267 0.015 CID_12297 | CID_12297 | |
| 0.283 | 0.059 | 0.5 | Hypoglycemic | 0.5 0.015 CID_12297 | CID_12297 | |
| 0.285 | 0.061 | 0.297 | Transcription factor STAT3 inhibitor | 0.297 0.055 CID_12297 | CID_12297 | |
| 0.246 | 0.024 | 0.253 | Phospholipase A2 inhibitor | 0.253 0.023 CID_12297 | CID_12297 | |
| 0.226 | 0.005 | 0.279 | Interferon agonist | 0.279 0.004 CID_12297 | CID_12297 | |
| 0.236 | 0.015 | 0.236 | Aminopeptidase B inhibitor | 0.234 0.015 CID_12297 | ||
| 0.245 | 0.024 | 0.251 | Interleukin 6 antagonist | 0.251 0.023 CID_12297 | CID_12297 | |
| 0.285 | 0.065 | 0.357 | Transcription factor STAT inhibitor | 0.357 0.032 CID_12297 | CID_12297 | |
| 0.283 | 0.064 | 0.486 | Cardiotonic | 0.486 0.017 CID_12297 | CID_12297 | |
| 0.224 | 0.004 | 0.224 | CDC25B inhibitor | 0.057 0.056 CID_12297 | ||
| 0.225 | 0.006 | 0.225 | Thioredoxin inhibitor | |||
| 0.235 | 0.018 | 0.249 | ATPase inhibitor | 0.249 0.014 CID_12297 | CID_12297 | |
| 0.257 | 0.04 | 0.361 | Non-steroidal antiinflammatory agent | 0.361 0.018 CID_12297 | CID_12297 | |
| 0.246 | 0.029 | 0.298 | Melanin inhibitor | 0.298 0.022 CID_12297 | CID_12297 | |
| 0.225 | 0.01 | 0.263 | Alcohol dehydrogenase inhibitor | 0.263 0.007 CID_12297 | CID_12297 | |
| 0.22 | 0.005 | 0.22 | Toll-Like receptor 3 antagonist | |||
| 0.248 | 0.034 | 0.248 | Thrombolytic | 0.23 0.039 CID_12297 | ||
| 0.231 | 0.018 | 0.231 | Cystathionine beta-synthase inhibitor | 0.152 0.04 CID_12297 | ||
| 0.236 | 0.024 | 0.245 | Nav1.2 sodium channel blocker | 0.245 0.023 CID_12297 | CID_12297 | |
| 0.224 | 0.015 | 0.232 | Nav1.1 sodium channel blocker | 0.232 0.014 CID_12297 | CID_12297 | |
| 0.211 | 0.002 | 0.211 | Calcium-dependent phospholipase A2 inhibitor | 0.04 0.004 CID_12297 | ||
| 0.217 | 0.009 | 0.249 | Glutamate dehydrogenase inhibitor | 0.249 0.007 CID_12297 | CID_12297 | |
| 0.228 | 0.021 | 0.228 | Cell wall synthesis inhibitor | 0.22 0.023 CID_12297 | ||
| 0.219 | 0.011 | 0.219 | Calcium antagonist | 0.177 0.016 CID_12297 | ||
| 0.231 | 0.024 | 0.231 | Neurotensin receptor agonist | 0.167 0.066 CID_12297 | ||
| 0.227 | 0.022 | 0.227 | Histone deacetylase SIRT1 inhibitor | 0.118 0.093 CID_12297 | ||
| 0.211 | 0.007 | 0.238 | Carbamoyl phosphate synthetase inhibitor | 0.238 0.006 CID_12297 | CID_12297 | |
| 0.218 | 0.014 | 0.218 | CF transmembrane conductance regulator agonist | 0.173 0.044 CID_12297 | ||
| 0.209 | 0.006 | 0.209 | CDC25A inhibitor | 0.116 0.02 CID_12297 | ||
| 0.234 | 0.033 | 0.352 | Amylase inhibitor | 0.352 0.013 CID_12297 | CID_12297 | |
| 0.208 | 0.006 | 0.217 | Glutamate decarboxylase inhibitor | 0.217 0.005 CID_12297 | CID_12297 | |
| 0.214 | 0.014 | 0.214 | Carbonic anhydrase III inhibitor | 0.133 0.036 CID_12297 | ||
| 0.23 | 0.032 | 0.23 | Antipruritic | 0.187 0.058 CID_12297 | ||
| 0.207 | 0.01 | 0.213 | NADH dehydrogenase inhibitor | 0.213 0.009 CID_12297 | CID_12297 | |
| 0.201 | 0.004 | 0.201 | Glycine receptor agonist | 0.133 0.009 CID_12297 | ||
| 0.207 | 0.01 | 0.207 | Vanilloid 1 agonist | 0.196 0.013 CID_12297 | ||
| 0.201 | 0.005 | 0.201 | Acetylcholine release stimulant | 0.132 0.032 CID_12297 | ||
| 0.203 | 0.007 | 0.207 | Ornithine carbamoyltransferase inhibitor | 0.207 0.007 CID_12297 | CID_12297 | |
| 0.278 | 0.082 | 0.278 | Lipoxygenase inhibitor | 0.225 0.118 CID_12297 | ||
| 0.194 | 0.004 | 0.194 | Glycine receptor antagonist | 0.142 0.009 CID_12297 | ||
| 0.195 | 0.005 | 0.195 | Lanosterol 14 alpha demethylase inhibitor | 0.167 0.007 CID_12297 | ||
| 0.206 | 0.016 | 0.206 | Falcipain 3 inhibitor | 0.133 0.045 CID_12297 | ||
| 0.28 | 0.092 | 0.28 | 12-Lipoxygenase inhibitor | |||
| 0.205 | 0.017 | 0.205 | Cyclooxygenase 3 inhibitor | 0.177 0.029 CID_12297 | ||
| 0.204 | 0.018 | 0.204 | Carbonic anhydrase XV inhibitor | 0.105 0.06 CID_12297 | ||
| 0.205 | 0.023 | 0.205 | 5-Lipoxygenase inhibitor | |||
| 0.188 | 0.006 | 0.188 | Lipase inhibitor | 0.104 0.025 CID_12297 | ||
| 0.217 | 0.035 | 0.217 | Acetylcholine M1 receptor antagonist | 0.171 0.057 CID_12297 | ||
| 0.239 | 0.061 | 0.239 | Anticonvulsant | |||
| 0.183 | 0.007 | 0.189 | Biliverdin reductase inhibitor | 0.189 0.006 CID_12297 | CID_12297 | |
| 0.183 | 0.009 | 0.199 | Toll-Like receptor 4 antagonist | 0.199 0.006 CID_12297 | CID_12297 | |
| 0.198 | 0.025 | 0.198 | Nav1.3 sodium channel blocker | 0.181 0.032 CID_12297 | ||
| 0.279 | 0.105 | 0.279 | Thyroid hormone antagonist | |||
| 0.209 | 0.036 | 0.209 | Thiol protease inhibitor | 0.167 0.056 CID_12297 | ||
| 0.203 | 0.03 | 0.203 | Toll-Like receptor antagonist | 0.147 0.058 CID_12297 | ||
| 0.178 | 0.005 | 0.178 | Sphingosine 1-phosphate receptor 4 agonist | 0.151 0.008 CID_12297 | ||
| 0.175 | 0.006 | 0.175 | Glutamate release inhibitor | 0.154 0.009 CID_12297 | ||
| 0.173 | 0.004 | 0.2 | Aconitate hydratase inhibitor | 0.2 0.003 CID_12297 | CID_12297 | |
| 0.226 | 0.057 | 0.226 | DNA methyltransferase I inhibitor | 0.223 0.058 CID_12297 | ||
| 0.188 | 0.019 | 0.188 | 5 Hydroxytryptamine 3A agonist | |||
| 0.211 | 0.043 | 0.211 | Cytidine deaminase inhibitor | 0.176 0.059 CID_12297 | ||
| 0.176 | 0.008 | 0.176 | Anabolic | 0.172 0.009 CID_12297 | ||
| 0.191 | 0.024 | 0.196 | Antibacterial (Helicobacter pylori) | 0.196 0.023 CID_12297 | CID_12297 | |
| 0.17 | 0.003 | 0.17 | Lysophosphatidic acid 2 receptor antagonist | 0.117 0.004 CID_12297 | ||
| 0.18 | 0.015 | 0.18 | Histidine decarboxylase inhibitor | 0.172 0.016 CID_12297 | ||
| 0.169 | 0.007 | 0.169 | Ornithine decarboxylase inhibitor | 0.149 0.011 CID_12297 | ||
| 0.189 | 0.03 | 0.249 | Alkylator | 0.249 0.017 CID_12297 | CID_12297 | |
| 0.174 | 0.015 | 0.174 | Heat shock protein 70 antagonist | 0.146 0.056 CID_12297 | ||
| 0.175 | 0.016 | 0.178 | Sphingosine 1-phosphate receptor 2 agonist | 0.178 0.015 CID_12297 | CID_12297 | |
| 0.245 | 0.087 | 0.345 | Antioxidant | 0.345 0.048 CID_12297 | CID_12297 | |
| 0.178 | 0.02 | 0.178 | Pregnane X receptor agonist | 0.136 0.084 CID_12297 | ||
| 0.265 | 0.108 | 0.265 | Thyroid hormone beta antagonist | |||
| 0.161 | 0.004 | 0.201 | Interferon inducer | 0.201 0.003 CID_12297 | CID_12297 | |
| 0.168 | 0.014 | 0.168 | DOPA decarboxylase inhibitor | 0.122 0.043 CID_12297 | ||
| 0.21 | 0.056 | 0.21 | Histone acetyltransferase inhibitor | |||
| 0.179 | 0.026 | 0.215 | Microtubule formation inhibitor | 0.215 0.017 CID_12297 | CID_12297 | |
| 0.181 | 0.029 | 0.181 | Farnesoid X receptor antagonist | |||
| 0.197 | 0.045 | 0.197 | Diuretic | 0.164 0.066 CID_12297 | ||
| 0.156 | 0.005 | 0.156 | Granulocyte macrophage colony stimulating factor agonist | 0.1 0.035 CID_12297 | ||
| 0.171 | 0.022 | 0.205 | Mucolytic | 0.205 0.012 CID_12297 | CID_12297 | |
| 0.167 | 0.02 | 0.167 | HIV-1 integrase (Overall Integration) inhibitor | 0.092 0.063 CID_12297 | ||
| 0.161 | 0.014 | 0.161 | CYP2A6 inhibitor | 0.072 0.056 CID_12297 | ||
| 0.216 | 0.069 | 0.228 | DNA methylase inhibitor | 0.228 0.062 CID_12297 | CID_12297 | |
| 0.155 | 0.009 | 0.155 | Leukotriene synthesis inhibitor | 0.112 0.02 CID_12297 | ||
| 0.22 | 0.074 | 0.568 | Interleukin antagonist | 0.568 0.014 CID_12297 | CID_12297 | |
| 0.198 | 0.053 | 0.198 | 3C-like protease (Human coronavirus) inhibitor | 0.134 0.133 CID_12297 | ||
| 0.184 | 0.04 | 0.184 | Mannose-6-phosphate isomerase inhibitor | 0.153 0.062 CID_12297 | ||
| 0.148 | 0.004 | 0.148 | Glutamate (mGluR6) antagonist | 0.113 0.007 CID_12297 | ||
| 0.272 | 0.129 | 0.292 | Toll-Like receptor agonist | 0.292 0.116 CID_12297 | CID_12297 | |
| 0.144 | 0.004 | 0.144 | Vanilloid 2 antagonist | 0.091 0.006 CID_12297 | ||
| 0.143 | 0.003 | 0.165 | Glucose-6-phosphate isomerase inhibitor | 0.165 0.002 CID_12297 | CID_12297 | |
| 0.152 | 0.012 | 0.166 | Aminopeptidase I inhibitor | 0.166 0.01 CID_12297 | CID_12297 | |
| 0.152 | 0.013 | 0.152 | Histamine N-methyltransferase inhibitor | |||
| 0.161 | 0.022 | 0.161 | Gastric antisecretory | 0.136 0.033 CID_12297 | ||
| 0.177 | 0.038 | 0.239 | Monophenol monooxygenase inhibitor | 0.239 0.025 CID_12297 | CID_12297 | |
| 0.142 | 0.004 | 0.142 | Sphingosine kinase 2 inhibitor | 0.137 0.004 CID_12297 | ||
| 0.152 | 0.014 | 0.152 | Keratolytic | 0.128 0.019 CID_12297 | ||
| 0.142 | 0.004 | 0.142 | Vanilloid 4 agonist | 0.124 0.005 CID_12297 | ||
| 0.18 | 0.042 | 0.19 | Hemostatic | 0.19 0.037 CID_12297 | CID_12297 | |
| 0.157 | 0.02 | 0.157 | Nitric-oxide synthase inhibitor | 0.093 0.072 CID_12297 | ||
| 0.163 | 0.027 | 0.163 | Interleukin 8 antagonist | 0.106 0.083 CID_12297 | ||
| 0.139 | 0.003 | 0.139 | Acetyl-CoA transferase 2 inhibitor | 0.066 0.022 CID_12297 | ||
| 0.177 | 0.042 | 0.177 | NADPH oxidase inhibitor | |||
| 0.149 | 0.013 | 0.177 | Peroxisome proliferator-activated receptor gamma agonist | 0.177 0.008 CID_12297 | CID_12297 | |
| 0.151 | 0.016 | 0.151 | Inducible nitric-oxide synthase inhibitor | 0.078 0.065 CID_12297 | ||
| 0.17 | 0.036 | 0.17 | Proteasome inhibitor | 0.157 0.042 CID_12297 | ||
| 0.138 | 0.004 | 0.138 | Phospholipase D inhibitor | 0.104 0.013 CID_12297 | ||
| 0.166 | 0.033 | 0.166 | Histone deacetylase class III inhibitor | |||
| 0.167 | 0.035 | 0.22 | Adenylate cyclase inhibitor | 0.22 0.022 CID_12297 | CID_12297 | |
| 0.138 | 0.008 | 0.138 | Elastase 1 inhibitor | 0.068 0.05 CID_12297 | ||
| 0.179 | 0.049 | 0.193 | Hexokinase inhibitor | 0.193 0.039 CID_12297 | CID_12297 | |
| 0.161 | 0.031 | 0.311 | Expectorant | 0.311 0.008 CID_12297 | CID_12297 | |
| 0.138 | 0.008 | 0.138 | Purinergic P2X1 antagonist | 0.108 0.014 CID_12297 | ||
| 0.133 | 0.004 | 0.204 | Sphingosine kinase inhibitor | 0.204 0.003 CID_12297 | CID_12297 | |
| 0.142 | 0.013 | 0.227 | Phenylalanine 4-hydroxylase inhibitor | 0.227 0.005 CID_12297 | CID_12297 | |
| 0.133 | 0.004 | 0.194 | Alpha-mannosidase inhibitor | 0.194 0.003 CID_12297 | CID_12297 | |
| 0.142 | 0.014 | 0.142 | Glutathione S-transferase inhibitor | 0.119 0.023 CID_12297 | ||
| 0.137 | 0.009 | 0.137 | Cannabinoid CB2 receptor antagonist | |||
| 0.161 | 0.033 | 0.161 | Beta amyloid protein antagonist | |||
| 0.149 | 0.021 | 0.149 | Cathepsin G inhibitor | 0.122 0.027 CID_12297 | ||
| 0.14 | 0.012 | 0.188 | Toll-Like receptor 2 agonist | 0.188 0.008 CID_12297 | CID_12297 | |
| 0.156 | 0.03 | 0.216 | Bronchodilator | 0.216 0.016 CID_12297 | CID_12297 | |
| 0.13 | 0.004 | 0.13 | Glutamate (mGluR7) antagonist | 0.094 0.014 CID_12297 | ||
| 0.137 | 0.012 | 0.137 | Cannabinoid CB1 receptor agonist | |||
| 0.152 | 0.027 | 0.152 | Caspase 3 inhibitor | 0.146 0.031 CID_12297 | ||
| 0.139 | 0.014 | 0.139 | Interleukin 5 antagonist | 0.126 0.02 CID_12297 | ||
| 0.136 | 0.011 | 0.344 | Prostaglandin EP2 antagonist | 0.344 0.004 CID_12297 | CID_12297 | |
| 0.135 | 0.011 | 0.135 | GABA aminotransferase inhibitor | 0.103 0.025 CID_12297 | ||
| 0.14 | 0.016 | 0.14 | Cannabinoid receptor antagonist | |||
| 0.135 | 0.011 | 0.135 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.214 | 0.09 | 0.214 | Antiamyloidogenic | 0.168 0.125 CID_12297 | ||
| 0.128 | 0.005 | 0.128 | Glucosylceramidase inhibitor | 0.127 0.005 CID_12297 | ||
| 0.13 | 0.007 | 0.13 | Estrogen-related receptor beta agonist | 0.101 0.024 CID_12297 | ||
| 0.131 | 0.008 | 0.131 | Acetylcholine M5 receptor agonist | 0.059 0.056 CID_12297 | ||
| 0.125 | 0.003 | 0.125 | Lysophosphatidic acid 3 receptor antagonist | 0.123 0.004 CID_12297 | ||
| 0.126 | 0.005 | 0.126 | Sphingosine 1-phosphate receptor 3 antagonist | 0.103 0.008 CID_12297 | ||
| 0.19 | 0.071 | 0.323 | Hepatoprotectant | 0.323 0.024 CID_12297 | CID_12297 | |
| 0.123 | 0.004 | 0.123 | Squalene epoxidase inhibitor | 0.072 0.013 CID_12297 | ||
| 0.148 | 0.029 | 0.148 | Mediator release inhibitor | 0.137 0.035 CID_12297 | ||
| 0.123 | 0.004 | 0.123 | Exportin-1 inhibitor | 0.108 0.006 CID_12297 | ||
| 0.145 | 0.027 | 0.145 | Transcription factor STAT6 inhibitor | |||
| 0.14 | 0.023 | 0.14 | Carbonic anhydrase VI inhibitor | 0.076 0.063 CID_12297 | ||
| 0.127 | 0.01 | 0.141 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.141 0.009 CID_12297 | CID_12297 | |
| 0.123 | 0.006 | 0.123 | Oleamide hydrolase inhibitor | 0.076 0.014 CID_12297 | ||
| 0.182 | 0.066 | 0.182 | Tumour necrosis factor antagonist | |||
| 0.129 | 0.014 | 0.129 | mTOR complex 2 inhibitor | 0.107 0.026 CID_12297 | ||
| 0.119 | 0.004 | 0.132 | Cytokine production stimulant | 0.132 0.003 CID_12297 | CID_12297 | |
| 0.213 | 0.098 | 0.464 | Tumour necrosis factor alpha release inhibitor | 0.464 0.018 CID_12297 | CID_12297 | |
| 0.119 | 0.005 | 0.217 | Mannosidase inhibitor | 0.217 0.003 CID_12297 | CID_12297 | |
| 0.148 | 0.035 | 0.148 | Nav1.4 sodium channel blocker | |||
| 0.118 | 0.005 | 0.118 | Nicotinic alpha3beta2 receptor antagonist | 0.05 0.043 CID_12297 | ||
| 0.119 | 0.006 | 0.119 | Cathepsin L2 inhibitor | |||
| 0.137 | 0.024 | 0.137 | Carbonic anhydrase XIII inhibitor | 0.09 0.043 CID_12297 | ||
| 0.122 | 0.009 | 0.186 | Neuraminidase inhibitor | 0.186 0.004 CID_12297 | CID_12297 | |
| 0.136 | 0.024 | 0.136 | Interleukin 1 beta converting enzyme inhibitor | 0.086 0.078 CID_12297 | ||
| 0.117 | 0.004 | 0.117 | Corticotropin releasing factor 2 receptor antagonist | 0.076 0.021 CID_12297 | ||
| 0.13 | 0.018 | 0.148 | Phosphodiesterase 6D inhibitor | 0.148 0.01 CID_12297 | CID_12297 | |
| 0.118 | 0.006 | 0.118 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.08 0.037 CID_12297 | ||
| 0.124 | 0.013 | 0.124 | Acetylcholine muscarinic agonist | |||
| 0.138 | 0.027 | 0.138 | Folate antagonist | 0.094 0.076 CID_12297 | ||
| 0.15 | 0.04 | 0.15 | Death-associated protein kinase 1 inhibitor | |||
| 0.124 | 0.014 | 0.124 | Carbonic anhydrase stimulant | 0.077 0.027 CID_12297 | ||
| 0.123 | 0.015 | 0.123 | Amidase inhibitor | 0.085 0.034 CID_12297 | ||
| 0.12 | 0.013 | 0.12 | Sphingosine 1-phosphate receptor antagonist | 0.096 0.025 CID_12297 | ||
| 0.116 | 0.009 | 0.116 | GABA B receptor agonist | 0.104 0.014 CID_12297 | ||
| 0.166 | 0.059 | 0.669 | Insulin secretagoues | 0.669 0.004 CID_12297 | CID_12297 | |
| 0.119 | 0.012 | 0.2 | Neuraminidase (influenza) inhibitor | 0.2 0.005 CID_12297 | CID_12297 | |
| 0.115 | 0.008 | 0.115 | Bombesin 3 receptor antagonist | |||
| 0.143 | 0.036 | 0.143 | Protein kinase C gamma inhibitor | 0.094 0.089 CID_12297 | ||
| 0.116 | 0.01 | 0.116 | CC chemokine 5 receptor agonist | 0.08 0.065 CID_12297 | ||
| 0.159 | 0.053 | 0.159 | Neuropeptide Y1 antagonist | |||
| 0.123 | 0.017 | 0.123 | Bile acid receptor antagonist | 0.106 0.037 CID_12297 | ||
| 0.109 | 0.004 | 0.109 | Dopamine D5 agonist | 0.055 0.014 CID_12297 | ||
| 0.118 | 0.014 | 0.118 | D-Ala-D-Ala ligase inhibitor | 0.093 0.039 CID_12297 | ||
| 0.145 | 0.041 | 0.145 | Alpha 2b adrenoreceptor antagonist | |||
| 0.11 | 0.007 | 0.11 | Sphingosine 1-phosphate receptor 5 agonist | 0.101 0.008 CID_12297 | ||
| 0.117 | 0.014 | 0.117 | NMDA receptor agonist | 0.072 0.035 CID_12297 | ||
| 0.116 | 0.013 | 0.116 | Carbonic anhydrase VB inhibitor | 0.059 0.036 CID_12297 | ||
| 0.109 | 0.006 | 0.109 | Potassium channel (Tandem pore domain) blocker | 0.081 0.031 CID_12297 | ||
| 0.114 | 0.012 | 0.114 | Cannabinoid CB1 receptor antagonist | 0.061 0.044 CID_12297 | ||
| 0.121 | 0.019 | 0.121 | Cannabinoid receptor agonist | |||
| 0.11 | 0.009 | 0.244 | Prostaglandin F2 alpha antagonist | 0.244 0.003 CID_12297 | CID_12297 | |
| 0.104 | 0.003 | 0.104 | Geranyltranstransferase inhibitor | 0.085 0.004 CID_12297 | ||
| 0.133 | 0.033 | 0.133 | Urease inhibitor | |||
| 0.108 | 0.009 | 0.108 | Fatty acid synthase inhibitor | 0.074 0.022 CID_12297 | ||
| 0.125 | 0.026 | 0.125 | Glutamate (mGluR7) agonist | |||
| 0.12 | 0.021 | 0.12 | Histamine H2 receptor antagonist | |||
| 0.102 | 0.004 | 0.166 | Sphingosine kinase 1 inhibitor | 0.166 0.003 CID_12297 | CID_12297 | |
| 0.126 | 0.028 | 0.126 | Acetylcholine nicotinic antagonist | |||
| 0.101 | 0.004 | 0.101 | Delayed rectifier potassium channel blocker | 0.038 0.025 CID_12297 | ||
| 0.105 | 0.008 | 0.105 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.109 | 0.012 | 0.109 | Acetylcholine M1 receptor agonist | |||
| 0.135 | 0.038 | 0.15 | AMP-activated protein kinase stimulant | 0.15 0.028 CID_12297 | CID_12297 | |
| 0.116 | 0.019 | 0.116 | Na+ K+ transporting ATPase inhibitor | 0.115 0.02 CID_12297 | ||
| 0.144 | 0.048 | 0.144 | Acetylcholine muscarinic antagonist | 0.104 0.086 CID_12297 | ||
| 0.115 | 0.019 | 0.115 | Acetylcholine M4 receptor antagonist | |||
| 0.101 | 0.005 | 0.135 | Fumarate hydratase inhibitor | 0.135 0.004 CID_12297 | CID_12297 | |
| 0.128 | 0.034 | 0.128 | Acetylcholine agonist | |||
| 0.112 | 0.018 | 0.112 | Caspase 7 inhibitor | |||
| 0.099 | 0.005 | 0.105 | Calcium channel P-type blocker | 0.105 0.005 CID_12297 | CID_12297 | |
| 0.116 | 0.023 | 0.125 | Selectin antagonist | 0.125 0.021 CID_12297 | CID_12297 | |
| 0.106 | 0.013 | 0.106 | Potassium channel (ATP-sensitive) blocker | |||
| 0.181 | 0.088 | 0.181 | I kappa B kinase epsilon inhibitor | |||
| 0.097 | 0.004 | 0.097 | Ryanodine receptor antagonist | 0.07 0.018 CID_12297 | ||
| 0.102 | 0.009 | 0.102 | Sphingosine 1-phosphate receptor 1 antagonist | 0.085 0.013 CID_12297 | ||
| 0.096 | 0.004 | 0.096 | Pregnane X receptor antagonist | 0.07 0.014 CID_12297 | ||
| 0.097 | 0.005 | 0.097 | Cholesterol esterase inhibitor | 0.073 0.009 CID_12297 | ||
| 0.184 | 0.092 | 0.184 | MAP kinase kinase 2 inhibitor | |||
| 0.119 | 0.028 | 0.119 | Phosphodiesterase I inhibitor | |||
| 0.137 | 0.045 | 0.137 | DNA repair enzyme inhibitor | |||
| 0.094 | 0.003 | 0.094 | Kainate receptor agonist | 0.071 0.004 CID_12297 | ||
| 0.105 | 0.014 | 0.105 | NMDA receptor glycine site agonist | 0.068 0.038 CID_12297 | ||
| 0.106 | 0.016 | 0.106 | TRPA1 antagonist | |||
| 0.095 | 0.005 | 0.095 | AMPA 4 receptor antagonist | 0.041 0.024 CID_12297 | ||
| 0.095 | 0.005 | 0.095 | Adenylate cyclase 1 inhibitor | 0.071 0.011 CID_12297 | ||
| 0.103 | 0.014 | 0.124 | Beta 3 adrenoreceptor antagonist | 0.124 0.009 CID_12297 | CID_12297 | |
| 0.099 | 0.01 | 0.099 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.093 | 0.005 | 0.093 | Histamine H2 receptor agonist | |||
| 0.098 | 0.01 | 0.098 | Phosphodiesterase 1A inhibitor | |||
| 0.102 | 0.015 | 0.102 | Protease 3C (Human rhinovirus) inhibitor | 0.071 0.035 CID_12297 | ||
| 0.143 | 0.056 | 0.143 | Cholinergic antagonist | |||
| 0.09 | 0.004 | 0.09 | Membrane dipeptidase inhibitor | 0.079 0.005 CID_12297 | ||
| 0.103 | 0.017 | 0.103 | Bombesin 1 receptor agonist | |||
| 0.095 | 0.009 | 0.095 | Potassium channel Kv1.3 blocker | |||
| 0.103 | 0.018 | 0.103 | Cannabinoid CB2 receptor agonist | |||
| 0.107 | 0.023 | 0.107 | Adenosine A3 receptor antagonist | 0.077 0.047 CID_12297 | ||
| 0.118 | 0.035 | 0.159 | Androgen antagonist | 0.159 0.02 CID_12297 | CID_12297 | |
| 0.116 | 0.033 | 0.116 | ABCA1 expression enhancer | 0.104 0.045 CID_12297 | ||
| 0.105 | 0.022 | 0.105 | Epoxide hydrolase inhibitor | 0.075 0.048 CID_12297 | ||
| 0.095 | 0.012 | 0.095 | Phosphodiesterase 1C inhibitor | |||
| 0.088 | 0.006 | 0.088 | Potassium channel (Inward rectifier) activator | |||
| 0.087 | 0.005 | 0.087 | Nicotinic acid receptor agonist | 0.066 0.01 CID_12297 | ||
| 0.155 | 0.073 | 0.155 | Protein-tyrosine phosphatase inhibitor | 0.153 0.075 CID_12297 | ||
| 0.139 | 0.057 | 0.139 | Acetylcholine antagonist | |||
| 0.097 | 0.016 | 0.097 | Androgen agonist | 0.064 0.036 CID_12297 | ||
| 0.106 | 0.025 | 0.106 | Carbonic anhydrase V inhibitor | |||
| 0.086 | 0.005 | 0.086 | Acetylcholine M4 receptor agonist | |||
| 0.088 | 0.007 | 0.138 | Adenosine deaminase inhibitor | 0.138 0.003 CID_12297 | CID_12297 | |
| 0.112 | 0.032 | 0.112 | Alpha 2d adrenoreceptor antagonist | |||
| 0.085 | 0.005 | 0.085 | Potassium channel (ATP-sensitive) activator | |||
| 0.103 | 0.024 | 0.103 | Carbonic anhydrase VA inhibitor | |||
| 0.125 | 0.046 | 0.125 | Estrogen antagonist | |||
| 0.085 | 0.006 | 0.085 | Kainate receptor 2 antagonist | |||
| 0.129 | 0.049 | 0.129 | GABA receptor agonist | |||
| 0.092 | 0.014 | 0.092 | Glycine transporter 2 inhibitor | |||
| 0.09 | 0.011 | 0.095 | MDM2 inhibitor | 0.095 0.009 CID_12297 | CID_12297 | |
| 0.083 | 0.005 | 0.083 | Alpha 1d adrenoreceptor agonist | |||
| 0.083 | 0.005 | 0.083 | Melatonin agonist | |||
| 0.081 | 0.005 | 0.081 | Angiotensin AT2 receptor antagonist | |||
| 0.106 | 0.029 | 0.106 | Myeloperoxidase inhibitor | |||
| 0.122 | 0.046 | 0.122 | Butyrylcholinesterase inhibitor | |||
| 0.094 | 0.019 | 0.097 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.097 0.018 CID_12297 | CID_12297 | |
| 0.219 | 0.144 | 0.219 | Caspase 3 stimulant | 0.216 0.147 CID_12297 | ||
| 0.122 | 0.046 | 0.154 | Xanthine oxidase inhibitor | 0.154 0.033 CID_12297 | CID_12297 | |
| 0.151 | 0.076 | 0.151 | Cholinergic | |||
| 0.08 | 0.006 | 0.08 | Immunoglobulin Fc receptor antagonist | 0.08 0.006 CID_12297 | ||
| 0.088 | 0.014 | 0.088 | Histone deacetylase SIRT3 inhibitor | 0.058 0.057 CID_12297 | ||
| 0.079 | 0.005 | 0.079 | Benzodiazepine antagonist | |||
| 0.078 | 0.005 | 0.078 | Glutamate (mGluR3) antagonist | 0.056 0.01 CID_12297 | ||
| 0.078 | 0.005 | 0.078 | Melatonin antagonist | |||
| 0.075 | 0.003 | 0.09 | Lysophosphatidic acid receptor 1 agonist | 0.09 0.002 CID_12297 | CID_12297 | |
| 0.08 | 0.008 | 0.08 | Leukotriene C antagonist | 0.08 0.008 CID_12297 | ||
| 0.106 | 0.034 | 0.106 | Bromodomain-containing protein 2 inhibitor | |||
| 0.092 | 0.02 | 0.092 | Acetylcholine M5 receptor antagonist | 0.055 0.05 CID_12297 | ||
| 0.095 | 0.024 | 0.127 | Leukotriene antagonist | 0.127 0.014 CID_12297 | CID_12297 | |
| 0.076 | 0.005 | 0.091 | Neuraminidase (Influenza A) inhibitor | 0.091 0.004 CID_12297 | CID_12297 | |
| 0.075 | 0.004 | 0.075 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.054 0.011 CID_12297 | ||
| 0.083 | 0.012 | 0.083 | Purinergic P2Y antagonist | 0.083 0.012 CID_12297 | ||
| 0.072 | 0.002 | 0.077 | Lysophosphatidic acid receptor 3 agonist | 0.077 0.002 CID_12297 | CID_12297 | |
| 0.092 | 0.022 | 0.092 | MAP kinase kinase 7 inhibitor | 0.078 0.052 CID_12297 | ||
| 0.139 | 0.069 | 0.139 | Calcium channel blocker | 0.12 0.087 CID_12297 | ||
| 0.071 | 0.002 | 0.071 | Carbonic anhydrase X inhibitor | 0.057 0.002 CID_12297 | ||
| 0.071 | 0.002 | 0.071 | Carbonic anhydrase VIII inhibitor | 0.057 0.002 CID_12297 | ||
| 0.074 | 0.005 | 0.074 | Purinergic P2Y12 antagonist | 0.048 0.007 CID_12297 | ||
| 0.096 | 0.027 | 0.096 | Calcium channel L-type blocker | 0.069 0.054 CID_12297 | ||
| 0.071 | 0.002 | 0.071 | Calcium-independent phospholipase A2 inhibitor | 0.054 0.004 CID_12297 | ||
| 0.084 | 0.015 | 0.084 | Toll-Like receptor 8 antagonist | |||
| 0.187 | 0.118 | 0.271 | Peptidyltransferase inhibitor | 0.271 0.037 CID_12297 | CID_12297 | |
| 0.097 | 0.029 | 0.097 | Estrogen receptor alpha antagonist | |||
| 0.181 | 0.112 | 0.181 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.119 | 0.05 | 0.119 | Alpha 2c adrenoreceptor antagonist | |||
| 0.081 | 0.012 | 0.081 | Epithelial sodium channel blocker | 0.056 0.036 CID_12297 | ||
| 0.077 | 0.009 | 0.077 | Glutamate (mGluR1a) antagonist | 0.047 0.023 CID_12297 | ||
| 0.072 | 0.005 | 0.072 | Peptide deformylase inhibitor | 0.033 0.018 CID_12297 | ||
| 0.091 | 0.024 | 0.101 | Secretase beta inhibitor | 0.101 0.017 CID_12297 | CID_12297 | |
| 0.072 | 0.004 | 0.072 | Guanylate cyclase inhibitor | 0.065 0.008 CID_12297 | ||
| 0.08 | 0.013 | 0.08 | Potassium channel (Inward rectifier) blocker | |||
| 0.094 | 0.027 | 0.094 | Neuronal nicotinic receptor antagonist | |||
| 0.082 | 0.015 | 0.082 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.081 0.016 CID_12297 | ||
| 0.071 | 0.004 | 0.071 | Histamine H1 receptor agonist | |||
| 0.071 | 0.004 | 0.071 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.078 | 0.012 | 0.078 | Prolactin release inhibitor | |||
| 0.082 | 0.017 | 0.127 | Beta 1 adrenoreceptor antagonist | 0.127 0.006 CID_12297 | CID_12297 | |
| 0.079 | 0.013 | 0.079 | 5 Hydroxytryptamine 4 antagonist | 0.05 0.038 CID_12297 | ||
| 0.092 | 0.026 | 0.092 | Phosphodiesterase VI inhibitor | 0.088 0.03 CID_12297 | ||
| 0.067 | 0.002 | 0.067 | Vanilloid 2 agonist | 0.047 0.003 CID_12297 | ||
| 0.087 | 0.022 | 0.128 | Beta adrenoreceptor antagonist | 0.128 0.009 CID_12297 | CID_12297 | |
| 0.087 | 0.022 | 0.087 | 5 Hydroxytryptamine 2A agonist | |||
| 0.072 | 0.007 | 0.072 | Arginase inhibitor | 0.069 0.008 CID_12297 | ||
| 0.069 | 0.005 | 0.069 | Glutamate (mGluR8) agonist | 0.05 0.012 CID_12297 | ||
| 0.072 | 0.007 | 0.072 | Dopamine beta hydroxylase inhibitor | 0.049 0.032 CID_12297 | ||
| 0.084 | 0.02 | 0.084 | Phosphodiesterase 1B inhibitor | |||
| 0.178 | 0.115 | 0.178 | Aryl hydrocarbon receptor agonist | |||
| 0.072 | 0.009 | 0.127 | Phosphoglycerate kinase inhibitor | 0.127 0.005 CID_12297 | CID_12297 | |
| 0.067 | 0.004 | 0.125 | Prostaglandin D2 agonist | 0.125 0.002 CID_12297 | CID_12297 | |
| 0.073 | 0.01 | 0.073 | Dihydroorotase inhibitor | |||
| 0.072 | 0.01 | 0.072 | Retinoid X receptor agonist | 0.055 0.016 CID_12297 | ||
| 0.101 | 0.038 | 0.107 | Transcription factor NF kappa B stimulant | 0.107 0.033 CID_12297 | CID_12297 | |
| 0.074 | 0.012 | 0.074 | Histone deacetylase 7 inhibitor | |||
| 0.093 | 0.031 | 0.093 | Prostaglandin-E synthase inhibitor | |||
| 0.08 | 0.019 | 0.08 | Autotaxin inhibitor | |||
| 0.098 | 0.038 | 0.139 | Adrenaline agonist | 0.139 0.018 CID_12297 | CID_12297 | |
| 0.078 | 0.019 | 0.078 | Transcription factor RelA inhibitor | |||
| 0.064 | 0.004 | 0.064 | Angiotensin AT1 receptor antagonist | 0.057 0.008 CID_12297 | ||
| 0.064 | 0.005 | 0.106 | ATP citrate lysase inhibitor | 0.106 0.003 CID_12297 | CID_12297 | |
| 0.066 | 0.007 | 0.066 | Potassium channel Kv1.1 blocker | |||
| 0.065 | 0.006 | 0.065 | Melatonin 1 agonist | |||
| 0.064 | 0.004 | 0.064 | Vanilloid 3 antagonist | 0.044 0.014 CID_12297 | ||
| 0.075 | 0.016 | 0.075 | 5 Hydroxytryptamine 7 agonist | |||
| 0.065 | 0.006 | 0.065 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.043 0.017 CID_12297 | ||
| 0.073 | 0.015 | 0.073 | Dihydroorotate oxidase inhibitor | 0.051 0.049 CID_12297 | ||
| 0.066 | 0.008 | 0.066 | Purinergic P2T antagonist | |||
| 0.084 | 0.025 | 0.084 | Protein kinase C beta inhibitor | |||
| 0.069 | 0.011 | 0.069 | Glutamate (mGluR4) antagonist | |||
| 0.074 | 0.017 | 0.074 | Histamine agonist | |||
| 0.062 | 0.004 | 0.062 | Angiotensin II receptor antagonist | 0.049 0.007 CID_12297 | ||
| 0.078 | 0.021 | 0.085 | Thromboxane antagonist | 0.085 0.017 CID_12297 | CID_12297 | |
| 0.067 | 0.01 | 0.067 | Retinoid X alpha receptor agonist | 0.036 0.023 CID_12297 | ||
| 0.062 | 0.005 | 0.062 | Retinoid X receptor antagonist | 0.044 0.018 CID_12297 | ||
| 0.075 | 0.017 | 0.075 | Lipocortins synthesis agonist | 0.058 0.039 CID_12297 | ||
| 0.061 | 0.004 | 0.061 | Epoxide hydrolase 1 inhibitor | |||
| 0.071 | 0.014 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.008 CID_12297 | CID_12297 | |
| 0.073 | 0.016 | 0.073 | Thromboxane synthase inhibitor | 0.071 0.017 CID_12297 | ||
| 0.096 | 0.039 | 0.096 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.08 0.051 CID_12297 | ||
| 0.095 | 0.038 | 0.095 | Macrophage migration inhibitory factor inhibitor | |||
| 0.076 | 0.02 | 0.076 | Antimetabolite | 0.069 0.022 CID_12297 | ||
| 0.061 | 0.005 | 0.061 | Leukotriene B4 receptor 1 antagonist | 0.058 0.005 CID_12297 | ||
| 0.067 | 0.011 | 0.067 | Oxytocin agonist | 0.049 0.024 CID_12297 | ||
| 0.081 | 0.026 | 0.081 | 5 Hydroxytryptamine 3 agonist | |||
| 0.082 | 0.026 | 0.1 | Ribonucleotide reductase inhibitor | 0.1 0.021 CID_12297 | CID_12297 | |
| 0.07 | 0.014 | 0.07 | Aldosterone antagonist | 0.054 0.025 CID_12297 | ||
| 0.058 | 0.003 | 0.058 | Acid ceramidase inhibitor | 0.034 0.005 CID_12297 | ||
| 0.08 | 0.025 | 0.099 | Ribonucleoside-diphosphate reductase inhibitor | 0.099 0.019 CID_12297 | CID_12297 | |
| 0.07 | 0.015 | 0.07 | HCV NS3/NS4A protease inhibitor | 0.051 0.03 CID_12297 | ||
| 0.058 | 0.003 | 0.058 | Purinergic P2Y15 antagonist | 0.045 0.005 CID_12297 | ||
| 0.065 | 0.01 | 0.065 | GABA B receptor antagonist | 0.051 0.019 CID_12297 | ||
| 0.073 | 0.018 | 0.073 | Plasminogen activator inhibitor antagonist | |||
| 0.06 | 0.004 | 0.06 | Glutamate (mGluR1a) agonist | |||
| 0.06 | 0.005 | 0.06 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.07 | 0.015 | 0.07 | Prolyl endopeptidase inhibitor | |||
| 0.058 | 0.003 | 0.058 | Nicotinic acid receptor 2 antagonist | 0.035 0.008 CID_12297 | ||
| 0.071 | 0.016 | 0.081 | Beta 2 adrenoreceptor antagonist | 0.081 0.012 CID_12297 | CID_12297 | |
| 0.063 | 0.009 | 0.063 | Sirtuin 2 inhibitor | |||
| 0.073 | 0.019 | 0.078 | Thromboxane A2 antagonist | 0.078 0.016 CID_12297 | CID_12297 | |
| 0.064 | 0.011 | 0.086 | Sphingosine 1-phosphate receptor 1 agonist | 0.086 0.005 CID_12297 | CID_12297 | |
| 0.119 | 0.065 | 0.119 | Calcium channel N-type blocker | |||
| 0.174 | 0.12 | 0.219 | Free radical scavenger | 0.219 0.084 CID_12297 | CID_12297 | |
| 0.101 | 0.047 | 0.101 | Potassium channel activator | |||
| 0.057 | 0.004 | 0.086 | Prostaglandin F2 alpha agonist | 0.086 0.002 CID_12297 | CID_12297 | |
| 0.066 | 0.013 | 0.09 | Sphingosine 1-phosphate receptor agonist | 0.09 0.007 CID_12297 | CID_12297 | |
| 0.072 | 0.019 | 0.095 | Leukotriene B4 antagonist | 0.095 0.012 CID_12297 | CID_12297 | |
| 0.057 | 0.004 | 0.057 | Adenosine uptake inhibitor | |||
| 0.076 | 0.023 | 0.076 | Heat shock protein 90 beta antagonist | |||
| 0.13 | 0.077 | 0.13 | Toll-Like receptor 9 antagonist | |||
| 0.062 | 0.009 | 0.062 | GABA uptake inhibitor | 0.045 0.019 CID_12297 | ||
| 0.071 | 0.018 | 0.071 | Beta 2 adrenoreceptor agonist | 0.071 0.017 CID_12297 | ||
| 0.126 | 0.073 | 0.126 | Acetylcholinesterase inhibitor | |||
| 0.058 | 0.006 | 0.058 | Uridine phosphorylase inhibitor | 0.058 0.006 CID_12297 | ||
| 0.064 | 0.011 | 0.064 | Glutamate (mGluR group III) antagonist | |||
| 0.082 | 0.03 | 0.099 | Peroxisome proliferator-activated receptor gamma antagonist | 0.099 0.016 CID_12297 | CID_12297 | |
| 0.102 | 0.05 | 0.102 | Potassium channel (Voltage-sensitive) activator | |||
| 0.089 | 0.038 | 0.089 | Histone deacetylase SIRT2 inhibitor | |||
| 0.056 | 0.005 | 0.056 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 CID_12297 | ||
| 0.077 | 0.026 | 0.077 | Alpha 2 adrenoreceptor agonist | |||
| 0.071 | 0.02 | 0.071 | Carbonic anhydrase XIV inhibitor | 0.047 0.036 CID_12297 | ||
| 0.078 | 0.027 | 0.078 | NMDA 2C receptor antagonist | |||
| 0.054 | 0.003 | 0.054 | Hedgehog signaling activator | 0.047 0.004 CID_12297 | ||
| 0.128 | 0.077 | 0.128 | Alkaline phosphatase inhibitor | |||
| 0.08 | 0.029 | 0.08 | Acetylcholine M2 receptor antagonist | |||
| 0.059 | 0.009 | 0.218 | Prostaglandin agonist | 0.218 0.003 CID_12297 | CID_12297 | |
| 0.065 | 0.015 | 0.065 | 5-Alpha-reductase inhibitor | |||
| 0.065 | 0.015 | 0.065 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.056 | 0.006 | 0.056 | Melatonin receptor 1A agonist | |||
| 0.144 | 0.094 | 0.144 | Heat shock protein 90 alpha antagonist | |||
| 0.061 | 0.011 | 0.061 | Dihydropteroate synthase inhibitor | |||
| 0.064 | 0.014 | 0.064 | Kainate receptor antagonist | |||
| 0.066 | 0.016 | 0.066 | Heparanase inhibitor | 0.055 0.033 CID_12297 | ||
| 0.054 | 0.005 | 0.054 | Melatonin 1 antagonist | |||
| 0.066 | 0.017 | 0.066 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.082 | 0.033 | 0.082 | Sirtuin 1 inhibitor | 0.066 0.05 CID_12297 | ||
| 0.06 | 0.012 | 0.06 | Plasmepsin II inhibitor | 0.057 0.013 CID_12297 | ||
| 0.053 | 0.005 | 0.053 | Retinoid X alpha receptor antagonist | 0.038 0.017 CID_12297 | ||
| 0.056 | 0.007 | 0.056 | Leukotriene C4 antagonist | 0.054 0.008 CID_12297 | ||
| 0.069 | 0.021 | 0.069 | Bcl-xL inhibitor | |||
| 0.053 | 0.005 | 0.053 | Glutamate (mGluR1) agonist | 0.03 0.009 CID_12297 | ||
| 0.055 | 0.007 | 0.055 | Free fatty acid receptor 1 antagonist | 0.032 0.027 CID_12297 | ||
| 0.161 | 0.113 | 0.161 | Focal adhesion kinase 2 inhibitor | |||
| 0.064 | 0.016 | 0.064 | Leukocyte elastase inhibitor | |||
| 0.056 | 0.008 | 0.056 | Heme oxygenase inhibitor | 0.047 0.017 CID_12297 | ||
| 0.059 | 0.011 | 0.059 | Nicotinic acid receptor 2 agonist | |||
| 0.077 | 0.029 | 0.077 | Adenosine A1 receptor antagonist | |||
| 0.059 | 0.012 | 0.059 | Histone deacetylase 9 inhibitor | |||
| 0.06 | 0.014 | 0.06 | Thymidine kinase inhibitor | 0.055 0.016 CID_12297 | ||
| 0.071 | 0.024 | 0.071 | NMDA 2A receptor antagonist | |||
| 0.114 | 0.067 | 0.125 | Protein-tyrosine phosphatase 1B inhibitor | 0.125 0.059 CID_12297 | CID_12297 | |
| 0.056 | 0.01 | 0.056 | Potassium channel subfamily K member 3 blocker | |||
| 0.053 | 0.008 | 0.053 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.045 0.012 CID_12297 | ||
| 0.05 | 0.004 | 0.05 | Elastase 2B inhibitor | |||
| 0.05 | 0.004 | 0.05 | Elastase 3A inhibitor | |||
| 0.05 | 0.004 | 0.05 | Elastase 3B inhibitor | |||
| 0.052 | 0.006 | 0.052 | Kainate receptor 4 antagonist | |||
| 0.051 | 0.006 | 0.054 | Methionyl aminopeptidase 1 inhibitor | 0.054 0.005 CID_12297 | CID_12297 | |
| 0.066 | 0.021 | 0.073 | Bombesin 2 receptor antagonist | 0.073 0.019 CID_12297 | CID_12297 | |
| 0.199 | 0.153 | 0.199 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.05 | 0.005 | 0.05 | Elastase 2 inhibitor | |||
| 0.05 | 0.005 | 0.05 | Elastase 2A inhibitor | |||
| 0.048 | 0.004 | 0.048 | Toll-Like receptor 8 agonist | 0.038 0.004 CID_12297 | ||
| 0.093 | 0.049 | 0.093 | Acetylcholine M3 receptor agonist | |||
| 0.084 | 0.04 | 0.084 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.067 | 0.023 | 0.09 | Peroxisome proliferator-activated receptor alpha agonist | 0.09 0.015 CID_12297 | CID_12297 | |
| 0.154 | 0.11 | 0.232 | P-glycoprotein inhibitor | 0.232 0.048 CID_12297 | CID_12297 | |
| 0.144 | 0.101 | 0.261 | Nitric oxide antagonist | 0.261 0.049 CID_12297 | CID_12297 | |
| 0.072 | 0.029 | 0.072 | Glutamate (mGluR1) antagonist | |||
| 0.056 | 0.013 | 0.06 | Squalene synthetase inhibitor | 0.06 0.012 CID_12297 | CID_12297 | |
| 0.062 | 0.02 | 0.062 | Dopamine D2 agonist | |||
| 0.047 | 0.005 | 0.047 | Glutamate (mGluR3) agonist | 0.036 0.015 CID_12297 | ||
| 0.048 | 0.006 | 0.109 | Prostaglandin EP2 agonist | 0.109 0.003 CID_12297 | CID_12297 | |
| 0.055 | 0.014 | 0.079 | Sphingosine 1-phosphate receptor 3 agonist | 0.079 0.009 CID_12297 | CID_12297 | |
| 0.045 | 0.004 | 0.045 | Glucosylceramidase stimulant | |||
| 0.05 | 0.009 | 0.05 | AMPA 3 receptor antagonist | |||
| 0.11 | 0.069 | 0.11 | Nav1.5 sodium channel blocker | |||
| 0.053 | 0.013 | 0.053 | Diamine oxidase inhibitor | |||
| 0.044 | 0.005 | 0.044 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.096 | 0.056 | 0.096 | Protein kinase C zeta inhibitor | |||
| 0.048 | 0.009 | 0.048 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.043 0.011 CID_12297 | ||
| 0.087 | 0.048 | 0.087 | Acetylcholine nicotinic agonist | |||
| 0.109 | 0.071 | 0.109 | Calcium channel (voltage-sensitive) blocker | |||
| 0.041 | 0.003 | 0.057 | Neuraminidase (Influenza B) inhibitor | 0.057 0.002 CID_12297 | CID_12297 | |
| 0.043 | 0.004 | 0.043 | Estrogen-related receptor gamma antagonist | 0.03 0.015 CID_12297 | ||
| 0.069 | 0.031 | 0.069 | Cathepsin L inhibitor | |||
| 0.07 | 0.032 | 0.088 | Nitric oxide donor | 0.088 0.016 CID_12297 | CID_12297 | |
| 0.055 | 0.017 | 0.055 | Dopamine D3 agonist | |||
| 0.091 | 0.053 | 0.132 | ATPase (Vacuolar H+) inhibitor | 0.132 0.013 CID_12297 | CID_12297 | |
| 0.058 | 0.02 | 0.058 | NMDA receptor subunit 3B antagonist | |||
| 0.071 | 0.033 | 0.071 | Aromatase inhibitor | |||
| 0.089 | 0.052 | 0.105 | Hematopoietic | 0.105 0.031 CID_12297 | CID_12297 | |
| 0.068 | 0.031 | 0.068 | Cyclin D1 inhibitor | |||
| 0.043 | 0.006 | 0.043 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.055 | 0.018 | 0.055 | AICAR transformylase inhibitor | 0.04 0.038 CID_12297 | ||
| 0.063 | 0.026 | 0.063 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.04 | 0.004 | 0.04 | Ileal bile acid transport inhibitor | 0.035 0.004 CID_12297 | ||
| 0.06 | 0.024 | 0.06 | Carbonic anhydrase II stimulant | |||
| 0.048 | 0.012 | 0.048 | Histone deacetylase 10 inhibitor | |||
| 0.066 | 0.03 | 0.066 | Botulinum neurotoxin type A inhibitor | 0.061 0.036 CID_12297 | ||
| 0.052 | 0.017 | 0.052 | Dihydrofolate reductase inhibitor | |||
| 0.073 | 0.038 | 0.073 | Histone deacetylase inhibitor | |||
| 0.039 | 0.004 | 0.039 | Thyroid hormone alpha antagonist | |||
| 0.079 | 0.044 | 0.079 | Metalloproteinase-9 inhibitor | 0.07 0.055 CID_12297 | ||
| 0.142 | 0.107 | 0.142 | LIM domain kinase 1 inhibitor | |||
| 0.066 | 0.032 | 0.066 | Potassium channel (Ca-activated) blocker | |||
| 0.048 | 0.014 | 0.048 | Histone deacetylase class IV inhibitor | |||
| 0.048 | 0.014 | 0.048 | Histone deacetylase 11 inhibitor | |||
| 0.045 | 0.011 | 0.045 | Dipeptidyl peptidase II inhibitor | |||
| 0.084 | 0.05 | 0.084 | Ca(v)3.1 blocker | |||
| 0.05 | 0.016 | 0.05 | Cholecystokinin B agonist | |||
| 0.064 | 0.031 | 0.064 | Cyclin A1 inhibitor | |||
| 0.044 | 0.011 | 0.044 | Liver X receptor beta antagonist | |||
| 0.049 | 0.016 | 0.049 | Factor XIIIa inhibitor | |||
| 0.045 | 0.013 | 0.045 | Melatonin 2 agonist | |||
| 0.049 | 0.016 | 0.049 | Vascular adhesion protein 1 inhibitor | |||
| 0.059 | 0.026 | 0.059 | H+/K+-transporting ATPase inhibitor | |||
| 0.036 | 0.004 | 0.036 | Isoleucine-tRNA ligase inhibitor | 0.035 0.004 CID_12297 | ||
| 0.05 | 0.018 | 0.05 | Nerve growth factor antagonist | |||
| 0.054 | 0.023 | 0.054 | CC chemokine 4 receptor antagonist | |||
| 0.036 | 0.005 | 0.036 | Angiotensin AT1A receptor antagonist | |||
| 0.043 | 0.012 | 0.043 | Glucagon receptor antagonist | 0.041 0.013 CID_12297 | ||
| 0.037 | 0.006 | 0.045 | Toll-Like receptor 4 agonist | 0.045 0.004 CID_12297 | CID_12297 | |
| 0.088 | 0.057 | 0.088 | Antineoplastic alkaloid | |||
| 0.054 | 0.023 | 0.054 | Thymidylate synthase inhibitor | |||
| 0.036 | 0.005 | 0.121 | Prostacyclin agonist | 0.121 0.003 CID_12297 | CID_12297 | |
| 0.063 | 0.033 | 0.063 | Cathepsin B inhibitor | |||
| 0.148 | 0.117 | 0.148 | Pyruvate kinase inhibitor | |||
| 0.035 | 0.005 | 0.035 | Complement factor 1s inhibitor | |||
| 0.036 | 0.006 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.012 CID_12297 | ||
| 0.065 | 0.035 | 0.065 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.035 | 0.005 | 0.035 | Lysophosphatidic acid 1 receptor antagonist | 0.034 0.005 CID_12297 | ||
| 0.04 | 0.01 | 0.04 | Cathepsin K inhibitor | |||
| 0.041 | 0.012 | 0.057 | Cholesterol ester transfer protein antagonist | 0.057 0.005 CID_12297 | CID_12297 | |
| 0.033 | 0.003 | 0.04 | Thromboxane A2 agonist | 0.04 0.002 CID_12297 | CID_12297 | |
| 0.057 | 0.027 | 0.057 | Adenosine A2b receptor antagonist | |||
| 0.061 | 0.032 | 0.061 | Matrix metalloproteinase (membrane-type) inhibitor | 0.051 0.044 CID_12297 | ||
| 0.033 | 0.004 | 0.033 | Retinoid X beta receptor antagonist | 0.023 0.009 CID_12297 | ||
| 0.046 | 0.017 | 0.046 | MAP3K5 inhibitor | |||
| 0.032 | 0.003 | 0.032 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.009 CID_12297 | ||
| 0.098 | 0.069 | 0.098 | Estrogen receptor beta antagonist | |||
| 0.071 | 0.043 | 0.071 | Matrix metalloproteinase inhibitor | |||
| 0.036 | 0.008 | 0.036 | Thymidine phosphorylase inhibitor | 0.026 0.019 CID_12297 | ||
| 0.056 | 0.027 | 0.056 | Metalloproteinase-3 inhibitor | |||
| 0.043 | 0.014 | 0.043 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.084 | 0.056 | 0.084 | GABA A receptor agonist | |||
| 0.036 | 0.008 | 0.036 | Kainate receptor 1 antagonist | |||
| 0.045 | 0.017 | 0.045 | 5 Hydroxytryptamine 2B agonist | |||
| 0.035 | 0.006 | 0.116 | Prostaglandin EP4 agonist | 0.116 0.003 CID_12297 | CID_12297 | |
| 0.039 | 0.011 | 0.044 | Lysine carboxypeptidase inhibitor | 0.044 0.009 CID_12297 | CID_12297 | |
| 0.051 | 0.023 | 0.051 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.034 | 0.007 | 0.04 | Leukotriene B4 receptor 2 antagonist | 0.04 0.005 CID_12297 | CID_12297 | |
| 0.039 | 0.011 | 0.039 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.081 | 0.053 | 0.081 | Chymotrypsin inhibitor | |||
| 0.042 | 0.014 | 0.042 | AMPA 1 receptor antagonist | |||
| 0.046 | 0.018 | 0.055 | Calcitonin receptor agonist | 0.055 0.016 CID_12297 | CID_12297 | |
| 0.041 | 0.013 | 0.041 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.032 | 0.004 | 0.032 | Nicotinic acid receptor 1 antagonist | 0.016 0.014 CID_12297 | ||
| 0.036 | 0.008 | 0.16 | Prostaglandin E2 agonist | 0.16 0.003 CID_12297 | CID_12297 | |
| 0.131 | 0.104 | 0.131 | MAP kinase 3 inhibitor | |||
| 0.08 | 0.052 | 0.08 | Metalloproteinase-2 inhibitor | |||
| 0.044 | 0.017 | 0.044 | Histone deacetylase 2 inhibitor | |||
| 0.04 | 0.013 | 0.04 | Carboxypeptidase B inhibitor | 0.04 0.013 CID_12297 | ||
| 0.064 | 0.037 | 0.064 | Acetylcholine M3 receptor antagonist | |||
| 0.063 | 0.036 | 0.089 | Cathepsin E inhibitor | 0.089 0.018 CID_12297 | CID_12297 | |
| 0.082 | 0.056 | 0.082 | Thioredoxin reductase inhibitor | |||
| 0.029 | 0.003 | 0.029 | Carbonic anhydrase XI inhibitor | 0.018 0.005 CID_12297 | ||
| 0.09 | 0.064 | 0.09 | Potassium channel (Ca-activated) activator | |||
| 0.032 | 0.006 | 0.032 | Imidazoline I1 receptor antagonist | |||
| 0.118 | 0.092 | 0.118 | Cytokine production inhibitor | |||
| 0.041 | 0.015 | 0.041 | Carnitine palmitoyltransferase inhibitor | |||
| 0.041 | 0.016 | 0.041 | Glutamate (mGluR8) antagonist | |||
| 0.065 | 0.04 | 0.065 | Adenosine A2a receptor antagonist | |||
| 0.029 | 0.003 | 0.029 | Telomerase stimulant | 0.024 0.005 CID_12297 | ||
| 0.037 | 0.013 | 0.037 | Leukotriene D4 antagonist | 0.033 0.014 CID_12297 | ||
| 0.034 | 0.009 | 0.034 | Myristoyl transferase inhibitor | |||
| 0.076 | 0.051 | 0.076 | Alpha 2a adrenoreceptor antagonist | |||
| 0.04 | 0.015 | 0.04 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.053 | 0.029 | 0.053 | CD45 antagonist | 0.046 0.044 CID_12297 | ||
| 0.092 | 0.068 | 0.092 | MAP kinase kinase 1 inhibitor | 0.086 0.077 CID_12297 | ||
| 0.058 | 0.034 | 0.058 | GABA receptor antagonist | |||
| 0.034 | 0.01 | 0.034 | Sodium/glucose cotransporter 2 inhibitor | 0.034 0.01 CID_12297 | ||
| 0.046 | 0.023 | 0.046 | Neurokinin 2 agonist | |||
| 0.036 | 0.013 | 0.036 | Histone deacetylase 3 inhibitor | |||
| 0.046 | 0.022 | 0.046 | Cathepsin L1 inhibitor | |||
| 0.052 | 0.029 | 0.052 | Glutamate (mGluR group I) agonist | |||
| 0.047 | 0.024 | 0.047 | Histone deacetylase 8 inhibitor | |||
| 0.032 | 0.009 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 CID_12297 | ||
| 0.126 | 0.103 | 0.126 | Heat shock protein 90 antagonist | |||
| 0.044 | 0.022 | 0.044 | Melanocortin 1 antagonist | 0.038 0.026 CID_12297 | ||
| 0.032 | 0.01 | 0.033 | Sodium/glucose cotransporter inhibitor | 0.033 0.009 CID_12297 | CID_12297 | |
| 0.025 | 0.003 | 0.046 | Thromboxane agonist | 0.046 0.002 CID_12297 | CID_12297 | |
| 0.047 | 0.025 | 0.058 | Beta adrenoreceptor agonist | 0.058 0.009 CID_12297 | CID_12297 | |
| 0.066 | 0.044 | 0.066 | Neutrophil collagenase inhibitor | |||
| 0.065 | 0.044 | 0.065 | Adenosine A2 receptor antagonist | |||
| 0.028 | 0.006 | 0.028 | Retinoic acid beta receptor agonist | |||
| 0.048 | 0.027 | 0.048 | Phosphodiesterase 6C inhibitor | |||
| 0.065 | 0.044 | 0.065 | Dopamine D1 antagonist | |||
| 0.029 | 0.008 | 0.029 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.039 | 0.018 | 0.049 | Peroxisome proliferator-activated receptor delta agonist | 0.049 0.013 CID_12297 | CID_12297 | |
| 0.055 | 0.035 | 0.055 | Matrix metalloproteinase 1 inhibitor | |||
| 0.044 | 0.023 | 0.044 | NMDA receptor subunit 3A antagonist | |||
| 0.043 | 0.023 | 0.043 | G protein-coupled receptor agonist | 0.038 0.026 CID_12297 | ||
| 0.028 | 0.009 | 0.028 | 5 Hydroxytryptamine 4 agonist | |||
| 0.029 | 0.009 | 0.029 | 5-Alpha-reductase 2 inhibitor | |||
| 0.031 | 0.012 | 0.031 | Prostaglandin H2 antagonist | 0.023 0.02 CID_12297 | ||
| 0.028 | 0.009 | 0.028 | 5-Alpha-reductase 1 inhibitor | |||
| 0.059 | 0.039 | 0.059 | Calcium channel T-type blocker | |||
| 0.055 | 0.035 | 0.055 | GABA A receptor antagonist | |||
| 0.024 | 0.005 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.004 CID_12297 | ||
| 0.024 | 0.005 | 0.024 | NMDA receptor phencyclidine site antagonist | |||
| 0.031 | 0.012 | 0.031 | Thyroid hormone agonist | |||
| 0.025 | 0.006 | 0.025 | Alpha 2b adrenoreceptor agonist | |||
| 0.024 | 0.005 | 0.024 | Purinergic P2Y1 agonist | 0.018 0.008 CID_12297 | ||
| 0.023 | 0.005 | 0.023 | Angiotensin AT1B receptor antagonist | |||
| 0.061 | 0.043 | 0.061 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.082 | 0.064 | 0.082 | Alpha 2 adrenoreceptor antagonist | |||
| 0.023 | 0.005 | 0.023 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.058 | 0.04 | 0.058 | Xanthine dehydrogenase inhibitor | |||
| 0.043 | 0.025 | 0.043 | Nicotinic acid receptor 1 agonist | |||
| 0.058 | 0.04 | 0.058 | Dopamine uptake inhibitor | |||
| 0.048 | 0.03 | 0.048 | Carbonic anhydrase VII inhibitor | |||
| 0.044 | 0.026 | 0.044 | CDK5/p25 inhibitor | |||
| 0.025 | 0.007 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.014 CID_12297 | ||
| 0.055 | 0.038 | 0.055 | Human rhinovirus A protease inhibitor | |||
| 0.077 | 0.06 | 0.077 | Histamine H1 receptor antagonist | |||
| 0.041 | 0.024 | 0.041 | Glutamate (mGluR group II) antagonist | |||
| 0.025 | 0.008 | 0.025 | Factor XIII inhibitor | |||
| 0.026 | 0.009 | 0.057 | Vitamin D receptor antagonist | 0.057 0.004 CID_12297 | CID_12297 | |
| 0.036 | 0.019 | 0.036 | Liver X receptor beta agonist | |||
| 0.023 | 0.006 | 0.025 | Antibiotic Anthracycline-like | 0.025 0.005 CID_12297 | CID_12297 | |
| 0.031 | 0.015 | 0.063 | Prostaglandin EP4 antagonist | 0.063 0.007 CID_12297 | CID_12297 | |
| 0.036 | 0.02 | 0.036 | Histone deacetylase 4 inhibitor | |||
| 0.027 | 0.011 | 0.027 | Kainate receptor 5 antagonist | |||
| 0.019 | 0.003 | 0.019 | Angiotensin AT2 receptor agonist | |||
| 0.046 | 0.031 | 0.046 | Glutamate (mGluR5) agonist | |||
| 0.03 | 0.014 | 0.03 | Epoxide hydrolase 2 inhibitor | |||
| 0.037 | 0.021 | 0.037 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.074 | 0.059 | 0.074 | Glutamate receptor agonist | |||
| 0.03 | 0.015 | 0.03 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.021 | 0.006 | 0.031 | Vitamin D receptor agonist | 0.031 0.004 CID_12297 | CID_12297 | |
| 0.04 | 0.026 | 0.04 | Urate transporter 1 inhibitor | |||
| 0.022 | 0.008 | 0.022 | Estrogen-related receptor gamma agonist | |||
| 0.033 | 0.018 | 0.061 | Plasmepsin I inhibitor | 0.061 0.005 CID_12297 | CID_12297 | |
| 0.068 | 0.054 | 0.068 | NMDA 2 receptor antagonist | |||
| 0.058 | 0.044 | 0.058 | Collagenase 3 inhibitor | |||
| 0.018 | 0.004 | 0.018 | Corticotropin releasing factor antagonist | |||
| 0.033 | 0.02 | 0.033 | Potassium channel small-conductance Ca-activated activator | |||
| 0.035 | 0.022 | 0.035 | Histone deacetylase 5 inhibitor | |||
| 0.018 | 0.004 | 0.018 | Melatonin 2 antagonist | |||
| 0.039 | 0.025 | 0.042 | Farnesoid X receptor agonist | 0.042 0.021 CID_12297 | CID_12297 | |
| 0.019 | 0.006 | 0.019 | Melatonin receptor 1A antagonist | |||
| 0.02 | 0.007 | 0.02 | Nicotinic alpha4 receptor agonist | |||
| 0.053 | 0.04 | 0.053 | Lysine-specific demethylase 1A inhibitor | |||
| 0.027 | 0.014 | 0.027 | Dopamine autoreceptor agonist | |||
| 0.021 | 0.008 | 0.021 | CXC chemokine 5 receptor antagonist | |||
| 0.048 | 0.036 | 0.048 | Topoisomerase II beta inhibitor | |||
| 0.031 | 0.018 | 0.031 | 5 Hydroxytryptamine 1D agonist | |||
| 0.017 | 0.005 | 0.017 | Cyclin D2 inhibitor | |||
| 0.047 | 0.034 | 0.047 | AMPA receptor antagonist | |||
| 0.021 | 0.008 | 0.021 | Kainate receptor 3 antagonist | |||
| 0.017 | 0.005 | 0.017 | Glutamate (mGluR6) agonist | 0.011 0.01 CID_12297 | ||
| 0.028 | 0.016 | 0.028 | CXC chemokine 2 receptor antagonist | |||
| 0.042 | 0.03 | 0.042 | Carbonic anhydrase IV inhibitor | |||
| 0.093 | 0.081 | 0.093 | Beta glucuronidase inhibitor | |||
| 0.051 | 0.04 | 0.051 | Dipeptidyl peptidase inhibitor | |||
| 0.049 | 0.038 | 0.049 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.036 | 0.025 | 0.036 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.021 | 0.01 | 0.021 | Aminopeptidase A inhibitor | 0.021 0.01 CID_12297 | ||
| 0.015 | 0.005 | 0.015 | Imidazoline I2 receptor antagonist | |||
| 0.041 | 0.03 | 0.041 | Acetyl-CoA carboxylase inhibitor | |||
| 0.021 | 0.011 | 0.021 | Caspase 8 inhibitor | 0.019 0.015 CID_12297 | ||
| 0.019 | 0.008 | 0.019 | Adenosine A2a receptor agonist | |||
| 0.063 | 0.052 | 0.063 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.03 | 0.02 | 0.03 | AMPA 2 receptor antagonist | |||
| 0.085 | 0.075 | 0.085 | MAO A inhibitor | |||
| 0.02 | 0.009 | 0.02 | Alpha 2a adrenoreceptor agonist | |||
| 0.045 | 0.035 | 0.045 | Glycine transporter inhibitor | |||
| 0.02 | 0.01 | 0.02 | Alpha 2c adrenoreceptor agonist | |||
| 0.024 | 0.014 | 0.024 | Retinoic acid receptor agonist | |||
| 0.043 | 0.033 | 0.043 | Dipeptidyl peptidase IV inhibitor | |||
| 0.029 | 0.019 | 0.029 | Thrombin receptor antagonist | |||
| 0.04 | 0.03 | 0.04 | Liver X receptor alpha agonist | |||
| 0.018 | 0.009 | 0.018 | Adenosine A2 receptor agonist | |||
| 0.019 | 0.01 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | |||
| 0.019 | 0.01 | 0.021 | G-protein-coupled receptor 120 agonist | 0.021 0.008 CID_12297 | CID_12297 | |
| 0.037 | 0.028 | 0.037 | TRPM8 blocker | |||
| 0.066 | 0.057 | 0.066 | Benzodiazepine agonist | |||
| 0.035 | 0.027 | 0.035 | Delayed rectifier potassium channel activator | |||
| 0.035 | 0.027 | 0.035 | Potassium channel KCNQ activator | |||
| 0.027 | 0.019 | 0.027 | Retinoid X gamma receptor antagonist | |||
| 0.033 | 0.026 | 0.07 | HMG CoA reductase inhibitor | 0.07 0.004 CID_12297 | CID_12297 | |
| 0.027 | 0.019 | 0.029 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.029 0.018 CID_12297 | CID_12297 | |
| 0.05 | 0.042 | 0.05 | Elastase inhibitor | |||
| 0.048 | 0.04 | 0.048 | 5 Hydroxytryptamine 2 agonist | |||
| 0.054 | 0.047 | 0.054 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.044 | 0.036 | 0.044 | Parathyroid hormone antagonist | |||
| 0.18 | 0.172 | 0.18 | Prostaglandin dehydrogenase inhibitor | |||
| 0.019 | 0.012 | 0.019 | Histamine H4 receptor agonist | |||
| 0.131 | 0.124 | 0.131 | Amyloid beta aggregation inhibitor | |||
| 0.061 | 0.054 | 0.061 | Kallikrein 7 inhibitor | |||
| 0.083 | 0.076 | 0.083 | Polo-like kinase-1 inhibitor | |||
| 0.023 | 0.016 | 0.023 | CC chemokine 8 receptor antagonist | |||
| 0.023 | 0.016 | 0.023 | ICAM 1 antagonist | |||
| 0.019 | 0.012 | 0.019 | Cyclin T1 inhibitor | |||
| 0.022 | 0.015 | 0.022 | Geranylgeranyltransferase inhibitor | |||
| 0.024 | 0.018 | 0.024 | Histone deacetylase 1 inhibitor | |||
| 0.021 | 0.015 | 0.021 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.024 | 0.019 | 0.024 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.028 | 0.023 | 0.028 | Glutamate (mGluR2) antagonist | |||
| 0.051 | 0.046 | 0.064 | Angiotensin-converting enzyme inhibitor | 0.064 0.025 CID_12297 | CID_12297 | |
| 0.057 | 0.052 | 0.057 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.028 | 0.024 | 0.028 | MAP3K8 inhibitor | |||
| 0.024 | 0.02 | 0.024 | Histone deacetylase class IIb inhibitor | |||
| 0.029 | 0.024 | 0.029 | Histone deacetylase class IIa inhibitor | |||
| 0.059 | 0.055 | 0.059 | Aryl hydrocarbon receptor antagonist | |||
| 0.064 | 0.059 | 0.064 | Phosphodiesterase V inhibitor | |||
| 0.045 | 0.041 | 0.045 | Histamine H4 receptor antagonist | |||
| 0.036 | 0.031 | 0.036 | Histone deacetylase class I inhibitor | |||
| 0.032 | 0.028 | 0.032 | Progesterone antagonist | |||
| 0.051 | 0.048 | 0.051 | MAP kinase kinase 9 inhibitor | |||
| 0.023 | 0.02 | 0.023 | Histone deacetylase 6 inhibitor | |||
| 0.031 | 0.027 | 0.031 | Vanilloid 4 antagonist | |||
| 0.075 | 0.072 | 0.077 | NMDA receptor antagonist | 0.077 0.069 CID_12297 | CID_12297 | |
| 0.027 | 0.023 | 0.027 | RNA-directed RNA polymerase stimulant | |||
| 0.045 | 0.042 | 0.045 | CC chemokine receptor 2B antagonist | |||
| 0.092 | 0.089 | 0.092 | Factor V inhibitor | |||
| 0.049 | 0.046 | 0.049 | CC chemokine 2 receptor antagonist | |||
| 0.026 | 0.023 | 0.026 | LFA antagonist | |||
| 0.014 | 0.011 | 0.014 | CXC chemokine 4 receptor agonist | |||
| 0.008 | 0.005 | 0.008 | DNA topoisomerase III inhibitor | |||
| 0.026 | 0.023 | 0.026 | Histone deacetylase class II inhibitor | |||
| 0.033 | 0.031 | 0.033 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.007 | 0.004 | 0.007 | Integrin alpha5beta6 antagonist | |||
| 0.042 | 0.04 | 0.042 | Purinergic P2X4 antagonist | |||
| 0.059 | 0.057 | 0.059 | Alpha adrenoreceptor agonist | |||
| 0.012 | 0.011 | 0.012 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.031 | 0.03 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.026 | 0.025 | 0.026 | 5 Hydroxytryptamine 6 agonist | |||
| 0.046 | 0.045 | 0.144 | Neuropeptide agonist | 0.144 0.015 CID_12297 | CID_12297 | |
| 0.073 | 0.072 | 0.073 | Neuropeptide Y antagonist | |||
| 0.017 | 0.016 | 0.017 | Complement factor D inhibitor | |||
| 0.082 | 0.083 | 0.149 | Protease inhibitor | 0.149 0.03 CID_12297 | CID_12297 | |
| 0.017 | 0.017 | 0.019 | Peroxisome proliferator-activated receptor alpha antagonist | 0.019 0.016 CID_12297 | CID_12297 | |
| 0.036 | 0.038 | 0.037 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.033 CID_12297 | CID_12297 | |
| 0.03 | 0.032 | 0.037 | Peroxisome proliferator-activated receptor delta antagonist | 0.037 0.017 CID_12297 | CID_12297 | |
| 0.026 | 0.029 | 0.037 | DNA polymerase III inhibitor | 0.037 0.006 CID_12297 | CID_12297 | |
| 0.044 | 0.05 | 0.129 | Cathepsin D inhibitor | 0.129 0.01 CID_12297 | CID_12297 | |
| 0.019 | 0.024 | 0.025 | Beta 1 adrenoreceptor agonist | 0.025 0.013 CID_12297 | CID_12297 | |
| 0.034 | 0.04 | 0.055 | Growth hormone release inhibitor | 0.055 0.018 CID_12297 | CID_12297 | |
| 0.05 | 0.057 | 0.089 | Glucagon-like peptide 1 agonist | 0.089 0.028 CID_12297 | CID_12297 | |
| 0.2 | 0.207 | 0.319 | Antiobesity | 0.319 0.104 CID_12297 | CID_12297 | |
| 0.028 | 0.04 | 0.052 | p53 inhibitor | 0.052 0.013 CID_12297 | CID_12297 | |
| 0.107 | 0.123 | 0.175 | Papain-like protease (SARS coronavirus) inhibitor | 0.175 0.018 CID_12297 | CID_12297 | |
| 0.003 | 0.02 | 0.016 | DNA polymerase III subunit alpha inhibitor | 0.016 0.002 CID_12297 | CID_12297 | |
| 0.005 | 0.024 | 0.012 | Beta 3 adrenoreceptor agonist | 0.012 0.008 CID_12297 | CID_12297 | |
| 0.01 | 0.032 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.006 CID_12297 | CID_12297 | |
| 0.029 | 0.051 | 0.056 | Endothelin-converting enzyme inhibitor | 0.056 0.026 CID_12297 | CID_12297 | |
| 0.027 | 0.05 | 0.038 | Antibiotic Aminoglycoside-like | 0.038 0.023 CID_12297 | CID_12297 | |
| 0.054 | 0.078 | 0.197 | Antineoplastic antibiotic | 0.197 0.022 CID_12297 | CID_12297 | |
| 0.019 | 0.044 | 0.108 | Renin inhibitor | 0.108 0.005 CID_12297 | CID_12297 | |
| 0.011 | 0.038 | 0.026 | Human T-cell leukemia virus type I protease inhibitor | 0.026 0.01 CID_12297 | CID_12297 | |
| 0.008 | 0.045 | 0.017 | Calcium-sensing receptor antagonist | 0.017 0.009 CID_12297 | CID_12297 | |
| 0.015 | 0.054 | 0.048 | Prostacyclin antagonist | 0.048 0.014 CID_12297 | CID_12297 | |
| 0.013 | 0.056 | 0.05 | Prostaglandin EP3 antagonist | 0.05 0.01 CID_12297 | CID_12297 | |
| 0.031 | 0.075 | 0.049 | Protein 50S ribosomal subunit inhibitor | 0.049 0.041 CID_12297 | CID_12297 | |
| 0.029 | 0.085 | 0.048 | Microtubule stabilization | 0.048 0.03 CID_12297 | CID_12297 | |
| 0.022 | 0.085 | 0.064 | HIV-1 protease inhibitor | 0.064 0.01 CID_12297 | CID_12297 | |
| 0.071 | 0.137 | 0.167 | Interleukin 12 antagonist | 0.167 0.009 CID_12297 | CID_12297 | |
| 0.171 | 0.242 | 0.205 | Toll-Like receptor 7 agonist | 0.205 0.194 CID_12297 | CID_12297 | |
| 0.201 | 0.275 | 0.597 | Cyclophilin D inhibitor | 0.597 0.028 CID_12297 | CID_12297 | |
| 0.008 | 0.089 | 0.022 | Aminopeptidase P inhibitor | 0.022 0.018 CID_12297 | CID_12297 | |
| 0.077 | 0.184 | 0.211 | Interleukin 1 antagonist | 0.211 0.028 CID_12297 | CID_12297 | |
| 0.042 | 0.152 | 0.091 | Somatostatin 1 agonist | 0.091 0.041 CID_12297 | CID_12297 | |
| 0.054 | 0.216 | 0.207 | Interleukin 1b antagonist | 0.207 0.018 CID_12297 | CID_12297 | |
| 0.099 | 0.3 | 0.173 | Growth factor agonist | 0.173 0.097 CID_12297 | CID_12297 | |
| 0.026 | 0.264 | 0.113 | Antiadrenergic | 0.113 0.049 CID_12297 | CID_12297 | |
| 0.025 | 0.264 | 0.111 | Adrenaline antagonist | 0.111 0.048 CID_12297 | CID_12297 | |
| 0.051 | 0.318 | 0.125 | MAP3K9 inhibitor | 0.125 0.104 CID_12297 | CID_12297 | |
| 0.048 | 0.328 | 0.082 | 3C-Like protease (SARS coronavirus) inhibitor | 0.082 0.062 CID_12297 | CID_12297 | |
| 0 | 0.531 | 0.014 | Mannitol 2-dehydrogenase inhibitor | 0.014 0.003 CID_12297 | CID_12297 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |